Immunic, Inc.
IMUX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,579 | -$26,820 | -$25,473 | -$25,175 |
| Dep. & Amort. | $40 | $43 | $43 | $35 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,899 | $2,042 | $0 |
| Change in WC | $1,737 | $214 | $1,559 | $71 |
| Other Non-Cash | $3,662 | $55 | $53 | $2,106 |
| Operating Cash Flow | -$20,140 | -$24,609 | -$21,776 | -$22,963 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$67 | -$36 | -$47 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$67 | -$36 | -$47 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $65,395 | $0 | $0 | $77 |
| Stock Repurch. | $0 | $123 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$65,395 | $65,395 | $0 | $0 |
| Financing Cash Flow | $0 | $65,518 | $0 | $77 |
| Forex Effect | $29 | $133 | $459 | -$514 |
| Net Chg. in Cash | -$20,178 | $41,006 | -$21,364 | -$23,403 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55,310 | $14,304 | $35,668 | $59,071 |
| End Cash | $35,132 | $55,310 | $14,304 | $35,668 |
| Free Cash Flow | -$20,207 | -$24,645 | -$21,823 | -$22,966 |